The UF Health-led ReMission Alliance Against Brain Tumors announced the names of 12 partner institutions from across the U.S. and Canada that are teaming up to develop novel treatments to vastly improve quality of life and long-term survival for patients fighting malignant brain tumors.
Joining the UF Health team in the research collaborative, led by ReMission Alliance Directors Duane A. Mitchell, M.D., Ph.D., and William A. Friedman, M.D., are the following institutions and principal investigators:
- Children’s of Alabama — Girish Dhall, M.D.
- Children’s National Hospital — Eugene Hwang, M.D., and Roger Packer, M.D.
- Dana-Farber Cancer Institute and Broad Institute of MIT and Harvard — Keith L. Ligon, M.D., Ph.D.
- Dana-Farber Cancer Institute — David Reardon, M.D.
- Duke University Medical Center — John Sampson, M.D., Ph.D.
- MD Anderson Cancer Center — Amy Heimberger, M.D.
- Nationwide Children’s Hospital — Mohamed Shebl AbdelBaki, M.D.
- Sanford Burnham Prebys Medical Discovery Institute — Robert Wechsler-Reya, Ph.D.
- Stanford Medicine — Gerald Grant, M.D., and Sanjiv Gambhir, M.D., Ph.D.
- The Biodesign Institute at Arizona State University — Stephen Johnston, Ph.D.
- University of Toronto Hospital for Sick Children — Michael D. Taylor, M.D., Ph.D.